Latest News & Features
Europe
A landmark decision sees the European Patent Office confirm that once all original appeals are withdrawn, third-party interveners cannot continue proceedings. 30 September 2025
Americas
Complaint alleges the pair used Massachusetts company’s patented mRNA TALEN gene-editing technology without permission in multi-billion-dollar cancer therapy deals. 29 September 2025
Americas
Sweeping tariffs send shockwaves through the pharma sector, as experts warn of consumer detriment and supply chain risks. 26 September 2025
Europe
A new survey from LSIPR reveals that European patent practitioners are grappling with client budget constraints and fast-evolving technologies, with most expecting patenting challenges to increase over the next five years. 25 September 2025
Europe
The General Court has handed a win to generic drug makers including Teva and Mylan in the battle over multiple sclerosis drug Tecfidera. 25 September 2025
Careers
The firm’s Technology & Engineering team will be expanded with an expert in patent drafting, prosecution and opposition/defence work across AI, digital health and medical devices. 25 September 2025
Americas
A biotech firm specialising in mRNA therapies alleges AbbVie’s $2.1 billion Capstan purchase was built on stolen lipid nanoparticle trade secrets. 24 September 2025
Americas
As John Squires is confirmed as the US Patent and Trademark Office's new director, Sarah Speight gathers reaction, and asks: what would you ask the US’ chief IP executive? 23 September 2025
Americas
There are varying national eligibility requirements that distinguish between treatments of and diagnostics for animals and humans; it’s just a question of reformatting ‘method of treatment’ claims, write lawyers from Sterne Kessler. 23 September 2025
Americas
The pharma giant invalidates a university's patent while gaining FDA approval for a new subcutaneous version of Keytruda as it protects its $29.5-billion-a-year cancer drug ahead of a looming patent cliff. 22 September 2025